Browsing by Author Underhill, Craig

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2013Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionalsButow, Phyllis; Phillips, Fiona; White, Kathryn; Goldstein, David; Grimison, Peter; Raymond, Carmel; Sardelic, Frank; Simes, Robyn; Tse, Regina; Turley, Kim; Underhill, Craig; Yip, Desmond; Psychology; Psychology; Faculty of Nursing & MidwiferyAre visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals, Asia Pacific Journal of Clinical Oncology, vol.9, 3, 2013,pp 226-238
2016Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerPavlakis, Nick; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Wong, Nicole; Burns, Ivon; Jefford, Michael; Moylan, Eugene; Price, Timothy; Ransom, David; Schofield, Penelope; Tebbutt, Niall; Underhill, Craig; Ward, R; Wyld, David; Zannino, Diana; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreHope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer, Supportive Care in Cancer, vol.24, 1, 2016,pp 401-408
2016ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumoursGebski, Val; Khasraw, Mustafa; Pavlakis, Nick; Thavaneswaran, Subotheni; Wilson, Kate; Chantrill, Lorraine A; Day, Fiona; Desai, Jayesh; Elez, Elena; et al, Various; Jefford, Michael; Nott, Louise M; Segelov, Eva; Underhill, Craig; Waring, Paul; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours, BMC Cancer, vol.16, 1, 2016,pp 1-8
2009Mapping oncology services in regional and rural AustraliaWhite, Kathryn; Bartel, Rebecca; Begbie, Stephen; Goldstein, David; Grogan, Paul; Jong, Kathy; Snodgrass, Helen; Underhill, Craig; Yates, Patsy; Faculty of Nursing & MidwiferyMapping oncology services in regional and rural Australia, Australian Journal of Rural Health, vol.17, N/A, 2009,pp 321-329
2010Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancerPavlakis, Nick; Begbie, Stephen; Boyce, Adam; De Souza, P; Harvie, Rozelle; Khasraw, M; Lim, V; Marx, Gavin; McCowatt, S; Parnis, F; Underhill, Craig; Northern Clinical School: MedicineMulticentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer, Annals of Oncology, vol.21, 6,pp 1302-1307
2009An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate CancerBoyer, Michael; Gurney, Howard; Davis, Ian; Kotasek, Dusan; Pezaro, Carmel; Rosenthal, Mark; Soloman, Benjamin; Toner, Guy C.; Underhill, Craig; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead)An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer, American Journal of Clinical Oncology, vol.32, 4,pp 338-341
2016Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trialFerraro, Danielle Angela; Gebski, Val; Hall, Merryn; Pavlakis, Nick; Sjoquist, Katrin; Veillard, Anne-Sophie; Wong, Nicole; Cooray, Prasad; Ganju, V.; Price, Timothy; Shannon, Jenny; Strickland, A. H.; Tebbutt, Niall; Underhill, Craig; Varma, S; Young, Rosemary; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePanitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial, British Journal of Cancer, vol.114, 5, 2016,pp 505-509
2005A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.Boyer, Michael; Clarke, Stephen; Yip, Desmond; Beale, Philip; Childs, Annabel; Iglesias, Jose L.; Latz, Jane; Millward, Michael; Moylan, Eugene; Suri, Ajit; Underhill, Craig; White, Shane; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; MedicineA phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer., Lung cancer, vol.49,(3),2005,pp 401-412
2005Phase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLCBoyer, Michael; Hui, Rina; Yip, Desmond; Blackwell, T.; Chern, B.; Crombie, C.; Hawson, G.; Links, Matthew; Underhill, Craig; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); MedicinePhase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLC, Lung cancer, vol.49,(Sup.2),2005,pp S272-S273
2006Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.Shaw, Peter; Burrows, Jacqueline; Clarke, Kerrie; Dua, Ujjwal; Elliott, Suzanne; et, al; Gandhi, Maher K.; Lambley, Eleanore; Prince, H.Miles; Underhill, Craig; Wolf, Max; Children's Hospital Westmead: Paediatrics & Child HealthPlasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma., Clinical Cancer Research, vol.12,(2),2006,pp 460-464
2016Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM StudyGebski, Val; Khasraw, Mustafa; Pavlakis, Nick; Robledo, Kristy; Simes, Robert John; Thavaneswaran, Subotheni; Wilson, Kate; Chantrill, Lorraine A; Desai, Jayesh; Elez, Elena; et al, Various; Karapetis, Christos (Chris); Lunke, Sebastian; Nott, Louise M; Segelov, Eva; Underhill, Craig; Waring, Paul; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; School of Molecular Bioscience (SMB)Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2258-2264
2013Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapyBoland, Amy; Chatfield, Mark; Gebski, Val; Grimison, Peter; McDonald, Angus; Olver, Ian Norman; Stockler, Martin; Davis, Ian; Harrup, Rosemary; Kichenadasse, G; Singhal, Nimit; Thomson, Damien; Toner, Guy; Underhill, Craig; Northern Clinical School: Medicine; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Ctr for Values Ethics & Law in Med; School of Public Health: NH&MRC Clinical Trials CentreResults of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy, Supportive Care in Cancer, vol.21, 6, 2013,pp 1561-1568
2014Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyBoland, Amy; Fournier, Marion; Grimison, Peter; McDonald, Angus; O'Carrigan, Brent; Stockler, Martin; Clingan, P; Davis, I D; Hanning, F; Olver, Ian; Singhal, N; Thomson, D B; Toner, Guy C.; Underhill, Craig; Whitford, Hayley; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreTestosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study, Internal Medicine Journal, vol.44, 8, 2014,pp 813-817